These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy. Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918 [TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701 [TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer]. Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005 [TBL] [Abstract][Full Text] [Related]
6. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases]. Liu LY Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794 [TBL] [Abstract][Full Text] [Related]
7. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134 [TBL] [Abstract][Full Text] [Related]
8. Second-look laparotomy in carcinoma of the fallopian tube. Barakat RR; Rubin SC; Saigo PE; Lewis JL; Jones WB; Curtin JP Obstet Gynecol; 1993 Nov; 82(5):748-51. PubMed ID: 8414320 [TBL] [Abstract][Full Text] [Related]
9. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942 [TBL] [Abstract][Full Text] [Related]
10. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445 [TBL] [Abstract][Full Text] [Related]
11. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study. Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559 [TBL] [Abstract][Full Text] [Related]
12. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer. Baiocchi G; Grosso G; di Re E; Fontanelli R; Raspagliesi F; di Re F Gynecol Oncol; 1998 May; 69(2):151-6. PubMed ID: 9600823 [TBL] [Abstract][Full Text] [Related]
13. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment. Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018 [TBL] [Abstract][Full Text] [Related]
14. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy. Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400 [TBL] [Abstract][Full Text] [Related]
15. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival. Friedman RL; Eisenkop SM; Wang HJ Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812 [TBL] [Abstract][Full Text] [Related]
17. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer. Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249 [TBL] [Abstract][Full Text] [Related]
18. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome. Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801 [TBL] [Abstract][Full Text] [Related]
19. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]
20. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients. Obermair A; Sevelda P Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]